ACC 22: Results from the EMPULSE Study - Empagliflozin Proves Beneficial for Patients with HF

(5:36)

AHA 2021 Late-Breaker Discussion: The EMPULSE Trial

(5:9)

EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors

(5:21)

ESC TV at #AHA21 - Expert Perspectives on the EMPULSE Trial

(2:19)

EMPULSE Results

(7:10)

EMPULSE: empagliflozina en insuficiencia cardiaca aguda

(1:4:50)

Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE trial

(2:9)

Quality of life improvement with Empagliflizon - Results from EMPULSE Trial

(7:10)

EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. AHA2021

(7:24)

Estudo EMPULSE - empagliflozina para pacientes com IC aguda!

(2:56)

Hypoglycemia Risk With Empagliflozin

(42)

Empagliflozin - NICE Guidelines 2

(22)

NICE Guidelines on SGLT2 inhibitors

(34)

Prof. John McMurray | Contraindications for Empagliflozin

(1:37)

Empagliflozin in Patients with Heart Failure NEJM

(1:34)

Breaking News: SGLT2i in ACUTE Heart Failure

(3:44)

AHA 2019: Empagliflozin on Erythropoietin Levels – Dr David Mazer

(3:57)

RECOVERY Trial - Empagliflozin

(9:59)

Jardiance (Benefits of Jardiance)

(50)

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

(13:28)